These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8279)

  • 21. [Clinical study of the beta-blocker chlorpropanol (tobanum) in hypertension patients].
    Sirakova V; Penkov N; Kaponov Kh
    Vutr Boles; 1986; 25(1):35-41. PubMed ID: 2872751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A comparative evaluation of metoprolol and methyldopa in hypertension therapy (author's transl)].
    Muiesan G; Agabiti-Rosei E; Buoninconti R; Carotti A; Fariello R; Innocenti P; Solinas E; Toso M; Motolese M
    G Ital Cardiol; 1980; 10(11):1482-90. PubMed ID: 7202896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydralazine and beta-adrenergic blockade in the treatment of hypertension.
    Siitonen L; Jänne J; Keyriläinen O; Koskinen P; Leskinen O; Pitkäjärvi T; Reinikainen M
    Ann Clin Res; 1974 Dec; 6(6):341-6. PubMed ID: 4155933
    [No Abstract]   [Full Text] [Related]  

  • 24. A report on the clinical efficacy of nadolol--a new long acting beta-blocker.
    Hill LS; Fand RS
    Ir Med J; 1979 Dec; 72(12):522-9. PubMed ID: 44273
    [No Abstract]   [Full Text] [Related]  

  • 25. [Metoprolol, a new cardioselective beta blocking agent in the treatment of arterial hypertension].
    Pedersen OL
    Ugeskr Laeger; 1975 Sep; 137(39):2274-6. PubMed ID: 241148
    [No Abstract]   [Full Text] [Related]  

  • 26. [Longterm therapy of angina pectoris patients with a new beta-receptor blocker (author's transl)].
    Schaumann HJ; Diekmann HJ; Neuss H; Stegaru B
    MMW Munch Med Wochenschr; 1976 Sep; 118(36):1123-5. PubMed ID: 9583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metolazone in essential hypertension: the long-term clinical efficacy of a new diuretic.
    Dornfeld L; Kane RE
    Curr Ther Res Clin Exp; 1975 Oct; 18(4):527-33. PubMed ID: 810314
    [No Abstract]   [Full Text] [Related]  

  • 28. "Timolol in essential hypertension" a preliminary report.
    Okuwobi B; Ogunyemi O
    West Afr J Pharmacol Drug Res; 1977 Jun; 4(1):37-42. PubMed ID: 602178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of essential hypertension with combined vasodilation and beta-adrenergic blockade.
    Zacest R; Gilmore E; Koch-Weser J
    N Engl J Med; 1972 Mar; 286(12):617-22. PubMed ID: 4401216
    [No Abstract]   [Full Text] [Related]  

  • 30. [Comparison of the antihypertensive affectiveness of atenolol and methyldopa].
    Ambrosioni E; Costa FV; Magelli C; Malini PL; Magnani B
    G Clin Med; 1979 Aug; 60(8):666-75. PubMed ID: 398305
    [No Abstract]   [Full Text] [Related]  

  • 31. Dose-titrated, double-blind, cross-over comparison of a selective beta-blocker and methyldopa in the treatment of hypertension.
    Routledge PA; Zrinzo LV; Rao JG; Walden RJ; Davies DM; Rawlins MD
    Eur J Clin Pharmacol; 1977 Mar; 11(3):159-62. PubMed ID: 323023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Betaxolol versus nifedipine in the treatment of essential hypertension].
    Steiner A; Hany S; Bättig B; Jenni R; Troesch M; Willimann P; Graf A; Leutenegger F; Angehrn V; Beck G
    Schweiz Rundsch Med Prax; 1988 Oct; 77(41):1101-3. PubMed ID: 2907178
    [No Abstract]   [Full Text] [Related]  

  • 33. Long term non-selective and cardioselective beta-receptor blockade in hypertensive patients. Effects on circulatory parameters, catecholamines and renin activity under basal conditions and in connection with exercise and hypoglycemia.
    Hansson BG
    Acta Med Scand Suppl; 1976; 598():1-61. PubMed ID: 13611
    [No Abstract]   [Full Text] [Related]  

  • 34. A comparative study of metoprolol and methyldopa in the treatment of hypertension.
    Karachalios GN
    Int J Clin Pharmacol Ther Toxicol; 1983 Sep; 21(9):476-8. PubMed ID: 6629553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of indometacin and acetylsalicylic acid on the therapeutic effectiveness of talinolol in patients with essential hypertension.
    Sziegoleit W; Ehrhardt A; Haase P; Beitz J; Block HU; Fahr A
    Biomed Biochim Acta; 1984; 43(8-9):S463-6. PubMed ID: 6151396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. beta-Adrenoceptor blockers in the treatment of hypertension.
    Falase AO; Salako LA
    Afr J Med Med Sci; 1979; 8(1-2):13-8. PubMed ID: 45432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The antihypertensive effect of a new beta-adrenergic blocking drug metroprolol in combination with chlorthalidone].
    Jäättelä A; Pyöräiä K
    Duodecim; 1976; 92(11):597-603. PubMed ID: 7445
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comparison of clinical usefulness of beta-blocker in aged and younger essential hypertension. Double blind trial using bunitrolol].
    Kuramoto K; Ikeda M; Arakawa K; Inagaki Y; Kaneko Y; Masuyama Y; Yamazaki N; Tsuchiya M
    Nihon Ronen Igakkai Zasshi; 1984 Jan; 21(1):20-6. PubMed ID: 6145808
    [No Abstract]   [Full Text] [Related]  

  • 39. Controlled trial of guanethidine and methyldopa in moderate hypertension.
    Tarpley EL
    Curr Ther Res Clin Exp; 1974 Nov; 16(11):1187-96. PubMed ID: 4214653
    [No Abstract]   [Full Text] [Related]  

  • 40. The position of beta-blockers in antihypertensive therapy. Comparison with other antihypertensive agents.
    Brunner HR; Waeber B; Ferguson RK; Turini GA; Gavras H
    Cardiology; 1979; 64 Suppl 1():88-95. PubMed ID: 42489
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.